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Abstract
Background: The 26S proteasome contains six highly related
ATPases of the AAA family. We have developed a strategy that
allows selective inhibition of individual proteasomal ATPases in
the intact proteasome. Mutation of a threonine in the active site of
Sug1/Rpt6 or Sug2/Rpt4 to a cysteine sensitizes these proteins to
inactivation through alkylation by the sulfhydryl modifying agent
NEM. Using this technique the individual contributions of Sug1
and Sug2 to proteasome function can be assessed.
Results : We show that both Sug1 and Sug2 can be selectively
alkylated by NEM in the context of the intact 26S complex and as
predicted by structural modeling, this inactivates the ATPase
function. Using this technique we demonstrate that both Sug 1
and 2 are required for full peptidase activity of the proteasome and
that their functions are not redundant. Kinetic analysis suggests
that Sug2 may have an important role in maintaining the
interaction between the 19S regulatory complex and the 20S
proteasome. In contrast, inhibition of Sug1 apparently decreases
peptidase activity of the 26S proteasome by another mechanism.
Conclusions: These results describe a useful technique for the
selective inactivation of AAA proteins. In addition, they also
demonstrate that the functions of two related proteasomal AAA
proteins are not redundant, suggesting differential roles of
proteasomal AAA proteins in protein degradation. ß 2001
Elsevier Science Ltd. All rights reserved.
Keywords: Chemical inactivation; AAA proteins; Proteasomal
ATPases
1. Introduction
The AAA (ATPases Associated with diverse cellular
Activities) family is a large group of proteins that contain
one or two copies of a conserved 230 amino acid motif
called the AAA module [1]. They are involved in a wide
variety of processes including vesicle fusion, proteolysis,
transcriptional regulation, peroxisomal biogenesis, cell
cycle regulation, meiosis, microtubule severing and chap-
erone-like functions [2,1]. Within the well-conserved AAA
module are Walker A and B nucleotide binding motifs [3],
and ATPase activity or ATP dependence has been demon-
strated for many of these proteins (e.g. [4^6]). While the
AAA module is highly conserved in all proteins of the
family, the proteins share less homology outside of the
AAA motif. Nonetheless, there is signi¢cant similarity
outside of the AAA module between proteins with related
functions [3]. It seems likely that the AAA module per-
forms a function that is localized or adapted to di¡erent
tasks by the non-AAA module regions of the molecules.
The function of the AAA module is not known, but many
AAA proteins are implicated in alteration of protein con-
formation, either reversible (chaperone-like activity, pro-
tein complex disassembly) or irreversible (unfolding before
proteolysis) [1].
The 26S proteasome is a complex macromolecular as-
sembly important for regulated protein degradation in
eukaryotic organisms as well as archaebacteria and some
eubacteria (for reviews, see [7,8]). Most substrates are tar-
geted for degradation by components of the ubiquitin sys-
tem through the covalent addition of a multiubiquitin
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chain [9]. The 26S proteasome is assembled from the 20S
proteolytic and 19S regulatory sub-complexes [10]. The
eukaryotic 20S proteasome contains 14 di¡erent subunits
arranged into four stacked, seven-member rings that form
a hollow cylinder [11]. The two inner rings are each com-
posed of seven di¡erent L-type subunits, some of which
have inward facing protease active sites, and two outer
rings are each made up of seven di¡erent K-subunits
[11]. The proteolytic active sites face the interior of the
cylinder and are thus sequestered from the cellular envi-
ronment, de¢ning the proteasome as a ‘self-compartmen-
talizing’ protease [7,12].
In the 20S proteasome of Thermoplasma there is a 1.3
nM pore at each pole of the 20S cylinder [13]. This is
su⁄cient to allow entry of peptides and unfolded proteins.
In the Saccharomyces cerevisiae proteasome this pore is
closed by overlapping loops of the K-type subunits [11].
Therefore, the pore must be opened before substrate can
gain entry. Consistent with this, the S. cerevisiae 20S pro-
teasome is usually puri¢ed in a ‘latent’ state that has very
little peptidase activity [14,15]. The peptidase activity can
be activated by treatments such as the addition of a low
concentration of SDS, which might disorder the loops
closing o¡ the pore and thus allow access the interior of
the cylinder [14,16]. While the SDS-activated complex is
competent to degrade peptides, it can not degrade pro-
teins. Recently, Groll and colleagues demonstrated that
deletion of the N-terminal tails of the yeast 20S K-type
subunits rendered the proteasomes fully active in vivo
for both peptidase and protease activity [17].
Protein degradation by the proteasome requires assem-
bly of the 20S with the 19S regulatory complex to form the
26S holocomplex [14]. The holocomplex is activated for
peptidase activity and is capable of degrading Ub-conju-
gated proteins, a process that requires the hydrolysis of
ATP [8]. The 19S regulatory complex of yeast is made
up of at least 17 di¡erent subunits with a total molecular
weight of approximately 700 kDa [14]. These subunits in-
clude six di¡erent ATPases of the AAA family. The genes
for each of these ATPases are essential for the growth of
yeast. The six ATPases are assumed to be responsible for
the known ATP dependence of several proteasome func-
tions. First, the association of the 19S and 20S complexes
to form the 26S proteasome is ATP dependent [10]. Sec-
ond, assembly of the 26S proteasome activates the pepti-
dase activity of the 20S proteasome, possibly by opening
the closed axial pore [18]. Rearrangement of the K-subunit
loops to open the pore might be an ATP dependent action.
Third, degradation of proteins by the proteasome requires
ATP, presumably because substrates must be unfolded so
that they can pass through the opened axial pore [19].
Fourth, ATP hydrolysis might be required for transloca-
tion of the unfolded proteins into the interior of the 20S
and this activity might be linked to unfolding. There are
no direct biophysical experiments proving a direct link
between any of these activities and the ATPase activity
of any speci¢c AAA proteins. It is not clear if all of the
ATPases are involved in each of these putative activities,
or if there might be di¡erentiation of functions between
the ATPases.
To test the idea that di¡erent AAA ATPases in the 19S
complex have di¡erent activities it is necessary to ablate
the activity of just one of the ATPases and assay the
functions of 26S complex lacking that activity. A simple
approach would be to genetically delete the gene in ques-
tion. However, all of the AAA proteins in the proteasome
are essential for growth. A second strategy is to make
mutations expected to inactivate the protein’s function
but not disrupt its overall structure. However, mutations
in the proteasomal ATPases expected to dramatically re-
duce their ATPase activity proved lethal in four out of six
cases [20]. In such cases, temperature sensitive (ts) muta-
tions are often useful. However, these can be di⁄cult to
¢nd, and it is often not clear if the shift in temperature
results in a loss of activity, complete loss of structural
integrity of the protein, or dissolution of the protein com-
plex.
An ideal approach would be to ¢nd a drug that acts
with high speci¢city on the active site of one of the ATP-
ases. Since the AAA protein modules are very similar in
sequence, especially in the nucleotide binding site [3], ¢nd-
ing such a drug seems unlikely. An alternative approach is
to make the protein of interest sensitive to a drug by a
mutation that does not a¡ect its activity in the absence of
the drug. Toward this goal, we report a novel approach in
which we are able to selectively sensitize individual ATP-
ases to alkylation by NEM. We have used this approach
to determine the contribution of individual ATPases to
overall proteasomal function.
2. Results
Our approach to selective inactivation of individual pro-
teasomal ATPases was suggested by a comparison be-
tween two AAA ATPases which are functional orthologs.
NSF is a AAA protein involved in membrane fusion. As
its name suggests, NSF (N-ethylmaleimide sensitive fusion
protein) is exquisitely sensitive to the sulfhydryl modifying
agent N-ethylmaleimide (NEM) and this property led to
its identi¢cation and isolation [21]. The yeast homolog of
NSF, Sec18, can substitute for NSF in a mammalian
vesicle fusion assay [21]. However, Sec18 is much less sen-
sitive to NEM. While NSF in cell extracts is inhibited by
exposure to 1 mM NEM for 15 min on ice, at least 5 mM
NEM is required to inhibit Sec18 under the same condi-
tions [22,21]. Since NEM is a sulfhydryl modifying reagent
[23], it has been suggested that a cysteine in the active site
of NSF is responsible for its sensitivity to NEM [24]. The
corresponding position in Sec18 is a threonine instead of a
cysteine (Fig. 1) perhaps accounting for the di¡erence in
NEM sensitivity between these two proteins. Of 237 AAA
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proteins having the consensus GPPGXGKT in the Walker
A box, 170 proteins (72%) have X = T, and 43 proteins
(18%) have X = C. Therefore, either T or C can be toler-
ated at this position in this group of highly homologous
AAA modules. All of the yeast proteasomal AAA ATP-
ases have a threonine at this position. Therefore, we
reasoned that we could sensitize these proteins to NEM
without crippling their ATPase activity by mutating the
conserved threonine to a cysteine in individual ATPases
(Fig. 1).
Modeling of the Sug1 ATP binding pocket suggests that
this is a reasonable strategy. The ATP binding pocket of
Sug1 was modeled based on the crystal structure of the D2
AAA module of NSF bound to the non-hydrolyzable ATP
analog AMP^PNP [25]. The substitution of cysteine for
threonine could be accommodated without any gross
structural change to the active site (Fig. 2). Further, alky-
lation of the cysteine with NEM is predicted to interfere
with ATP binding (Fig. 2). Speci¢cally, the NEM moiety
occupies much of the binding site for the L- and Q-phos-
phates of the ATP molecule. Therefore, we hypothesized
that a comparison of proteasome activity between NEM-
treated mutant and wild-type (WT) strains should allow us
to assess the consequences of blocking the ATP binding
and hydrolysis activities of individual ATPases. Interest-
ingly, the second position in the DExx box of NSF is an
aspartate which positions two water molecules that, in
turn, interact with the Q-phosphate and the Mg2. In
Sug1 this residue is a longer glutamate that can be mod-
eled to interact with the Mg2 ion and the Q-phosphate
oxygen directly.
To test this hypothesis, we produced a set of congenic
strains that di¡ered only in the identity of a single amino
acid in the Walker A box of a proteasomal ATPase.
Threonine to cysteine mutations were produced in two
proteasomal AAA proteins, Sug1/Rpt6 [26,27] and Sug2/
Rpt4 [16]. The mutant alleles were placed into their nor-
mal genomic locations by two step gene replacement to
Fig. 1. Strategy for selective inactivation of individual yeast AAA pro-
teins in the proteasome. The sequence of the Walker A box (nucleotide
binding loop) is listed. NEM sensitivities for NSF and Sec18 are as re-
ported by Wilson et al. [21]. All of the AAA proteins in the yeast 26S
proteasome have a threonine at the position occupied by a cysteine in
NSF and by a threonine in Sec18. We hypothesized that replacement of
this threonine with a cysteine would increase the sensitivity of these pro-
teins to alkylation by maleimides.
Fig. 2. Stereo view of the active site model for Sug1T193C with alkylation by NEM. The ATP binding sites of Sug1T193C was modeled based on the
structure of the D2 AAA module of NSF [25] (see Section 2). The Sug1 CK backbone trace is shown as a transparent ribbon diagram with the bound
Mg2 AMP^PNP (semi-transparent) and the cysteinyl-bound NEM (opaque) shown in a stick representation. Carbon atoms are shown in gray, oxygens
in red, nitrogens in blue, phosphorus in yellow and sulfur is shown in green. This ¢gure was prepared with Bobscript [37], Molscript [38] and Raster
3D [39,40].
CHBIOL 124 26-9-01 Cyaan Magenta Geel Zwart
Research Paper Functions of proteasomal ATPases S.J. Russell et al. 943
produce haploid strains containing either the SUG1T193C
or the SUG2T226C alleles which are otherwise WT. These
strains grow as well as the congenic WT and exhibit no
obvious phenotype (data not shown). These strains were
mated and the resulting diploid was sporulated. Segregants
from this cross were analyzed by PCR to identify WT,
single mutant (SUG1T193C or the SUG2T226C) and double
mutant (SUG1T193CSUG2T226C) isolates so that a congenic
set of strains was obtained. The Sug1 and Sug2 genes were
ampli¢ed from genomic DNA isolated from these strains
and sequenced to verify that only the desired mutations
were present.
Many strains with defects in proteasomal proteolysis
have obvious growth defects. Therefore, the growth char-
acteristics of our panel of strains were analyzed. All four
strains had the same doubling time at 30‡C and 37‡C in
rich medium. They also had the same doubling time at
37‡C in minimal medium (data not shown). Thus, these
strains had no growth defect even under stressful growth
conditions, suggesting that proteasome function is not
grossly altered. To detect more subtle defects, the pepti-
dase activity of the 26S proteasome from the mutant
strains was tested. As shown in Table 1, there is no sig-
ni¢cant change in the peptidase activity of the 26S protea-
some from either of the single mutant strains or the double
mutant strain. In some experiments there was a slight in-
crease in activity in the mutant strains, but this was not
always observed.
To determine whether the substitution of cysteine for
threonine in the nucleotide binding loop renders the mu-
tant proteins more susceptible to alkylation with male-
imides, we utilized 3-(N-maleimidopropionyl)-biocytin (bi-
otin maleimide) [28]. This molecule is composed of
maleimide attached to biotin through a long linker. We
treated whole cell extracts with biotin maleimide, then
quenched the reaction with excess DTT. Unreacted biotin
maleimide was removed by gel ¢ltration and the 26S pro-
teasome complex was dissociated with guanidinium hydro-
chloride. Biotinylated proteins were then isolated by bind-
ing to streptavidin agarose. Bound proteins were separated
by SDS^PAGE, and detected by Western blot. As can be
seen in Fig. 3, Sug1 was preferentially alkylated by biotin
maleimide in extract from the SUG1T193C strain as com-
pared to extracts of the WT and the SUG2T226C strains.
Conversely, Sug2 was preferentially alkylated in extracts
from the SUG2T226C strain. WT Sug1 contains four cys-
teines and WT Sug2 contains two cysteines. The preferen-
tial labeling of Sug1 and Sug2 in extracts of the mutant
strains is more dramatic than would be expected due to
the addition of one additional cysteine if all cysteines are
equally vulnerable to alkylation by biotin maleimide.
Therefore, the cysteines introduced into the active site
are uniquely accessible. This is not surprising, as the active
site is by de¢nition accessible to small molecules in solu-
tion. We cannot exclude that the mutations indirectly ac-
tivate another residue as a nucleophile. However, this
seems unlikely, and would not a¡ect the usefulness of
the method even if true. We conclude that Sug1 and
Sug2 proteins carrying the threonine to cysteine mutations
are preferentially targeted for alkylation by maleimide re-
agents.
To determine if alkylation of Sug1 and Sug2 has an
e¡ect on 26S proteasome function, we treated whole cell
extracts from our panel of congenic strains with NEM.
After excess NEM was quenched with DTT the peptidase
activity of the 26S proteasome against a proteasome spe-
ci¢c peptide substrate was assayed. Activity in this assay
requires that the 26S proteasome remains intact. To assay
the activity of the 20S proteasome alone, the 19S regula-
tory complex was dissociated from the 20S in the context
of the whole cell extract. Activity was then assayed in the
presence of 0.05% SDS which activates the latent 20S for
peptidase activity.
The puri¢ed 26S proteasome has been demonstrated to
be sensitive to NEM [29] and, as seen in Fig. 4A, NEM
inhibits 26S peptidase activity in a dose dependent manner
in all extracts. However, extracts of both single mutant
Table 1
Peptidase activity of the 26S proteasome from WT, SUG1T193C ,
SUG2T226C , and SUG1T193CSUG2T226C strains
Strain Normalized
peptidase activity
S.D. (n = 7)
WT 1
SUG1T193C 1.08 0.04
SUG2T226C 1.03 0.04
SUG1T193CSUG2T226C 1.09 0.05
Extracts of the indicated strains were assayed as described in Section 2.
Results presented are the means of seven determinations.
Fig. 3. Biotin maleimide di¡erentially alkylates Sug proteins that have
cysteines in their active sites. Extracts were treated with biotin male-
imide and alkylated proteins were isolated under denaturing conditions
using streptavidin agarose as described in Section 2. Western blots were
probed with polyclonal antibodies speci¢c for Sug1 or Sug2. Sug1 is
preferentially alkylated by biotin maleimide only in the SUG1T193C
strain and Sug2 is preferentially alkylated only in the SUG2T226C strain.
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strains are more sensitive to NEM than WT, and extracts
of the double mutant strain are more sensitive than the
extracts of single mutant strains. To make the di¡erential
e¡ect of NEM on extracts of the mutant strains more
clear, the peptidase activity was normalized to the activity
in the WT extract (Fig. 4B). As the dose of NEM increases
from 0 to 2 mM, there is a progressively larger di¡erence
between activity of the WT and mutant extracts. However,
after 2 mM there is no further increase in the di¡erential
e¡ect, even though the absolute activity continues to de-
crease (compare Fig. 4A and B). We interpret this to mean
that the mutant cysteines have been entirely alkylated by
NEM after treatment with 2 mM NEM. Further alkyla-
tion by larger doses of NEM results in alkylation of res-
idues which are common between the WT and mutant
proteins. The sensitivity of the WT extract is not primarily
due to NEM inhibition of the 20S proteasome. As can be
seen in Fig. 4A, there is relatively little inhibition of SDS
stimulated peptidase activity by NEM and there is no
di¡erence in inhibition between strains. Therefore, inhibi-
tion of 26S peptidase activity must be due to alkylation of
cysteines normally present in proteins of the 19S complex
besides Sug1 and Sug2. The critical point is that the sen-
sitivity of the mutant strains to NEM is increased. Since
the strains are otherwise identical, this increased sensitivity
must be due to the presence of the variant cysteines, and
thus likely due to the increased alkylation of Sug1 and
Sug2.
Mutations in both Sug1 and Sug2 lead to a similar in-
crease in NEM sensitivity of 25% compared to the WT
extract. The double mutant has a sensitivity to NEM
which is roughly the sum of the Sug1 and Sug2 e¡ects,
or approximately 50% inhibition of 26S peptidase activity
compared to WT. Therefore, the functions of Sug1 and
Sug2 are not redundant in activating the 20S proteasome
for peptidase activity. An important point is that approx-
imately 50% of 26S peptidase remains after both Sug1 and
Sug2 are maximally alkylated. This seems reasonable, as
only two of six ATPases have been di¡erentially alkylated.
However, this result, along with the additivity of the Sug1
and Sug2 e¡ects, means that the activity of the AAA ATP-
ases cannot be obligately coordinated. In other words, the
other ATPases must be able to function to some degree
even when Sug1 and Sug2 cannot.
At least two steps are necessary for the 19S to activate
the 20S for peptide hydrolysis ; binding to form the 26S
complex and pore opening. Peptidase assays done in the
absence of SDS measure the activity of intact 26S. If Sug1
C
Fig. 4. Sug1 and Sug2 have non-redundant functions in activation of
the 20S proteasome peptidase activity. (A) Normalized peptidase activity
of the 20S (+SDS) and 26S (3SDS) proteasomes. There is little e¡ect of
the concentrations of NEM used on the activity of the 20S proteasome
activated by SDS. In contrast, non-SDS stimulated activity that requires
activation by the 19S regulatory complex is inhibited in a dose depen-
dent manner by NEM. Strains carrying threonine to cysteine mutations
are more sensitive than WT strains. (B) Peptidase activity normalized to
the activity of the WT strain. This is a di¡erent representation of the
data in A. The SUG1T193C and SUG2T226C mutations have roughly
equivalent e¡ects and the e¡ects of the two mutants seems to be addi-
tive in the SUG1T193CSUG2T226C strain. The di¡erential e¡ect of NEM
on the mutant strains is saturated at 2 mM NEM. At greater concentra-
tions the inhibition of WT and mutant strains by NEM has the same
dose dependence.
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or Sug2 are important for the assembly and stability of the
26S complex, then NEM treatment of the mutant strains
should result in destabilization of the complex compared
to the similarly treated WT. In a kinetic assay we might
expect the rate of peptide hydrolysis to decrease with time
as the unstable 26S complex falls apart and thus loses
peptidase activity. On the other hand, if Sug1 or Sug2
were involved in pore opening or maintaining the open
position of the pore, then in a kinetic assay we would
expect a change in the initial rate of hydrolysis because
even stably assembled 26S proteasomes would have a de-
creased ability to admit substrate.
To determine if alkylation of Sug1 or Sug2 leads to
di¡erent e¡ects on 26S proteasome activity, we performed
kinetic assays on extracts from the congenic panel of
strains after treatment with NEM. The assays were per-
formed as in Fig. 4 except that after the addition of
treated extract to the substrate mix the concentration of
product was measured every 30 s. Fig. 5A shows the prog-
ress of product accumulation for extracts from WT and
mutant strains. Note that even in the WT extract that has
not been treated with NEM the accumulation of substrate
is not linear. Since substrate is not limiting even at the 30
min time point (data not shown), this implies that pepti-
dase activity is lost during the course of the assay, possibly
due to dissociation of the 26S proteasome into 19S and
latent 20S complexes. This interpretation is supported by a
graph of product accumulation by 20S proteasome acti-
vated by 0.05% SDS. The increase of product is linear and
equivalent between strains in these experiments (data not
shown).
In the absence of NEM treatment the mutant strains
show a small increase in activity compared to the WT in
this experiment. This was not always observed, and the
di¡erences were never large, consistent with the endpoint
assay data shown in Fig. 4. After treatment with NEM the
result is quite di¡erent (Fig. 5A,B). Even for the WT ex-
tract there is a more dramatic slowing of product accumu-
lation at later time points than in the absence of NEM
treatment. This suggests that alkylation of residues present
in the WT proteins of the 19S proteasome destabilize the
26S complex. Consistent with the endpoint assay (Fig. 4)
both single mutant extracts have similar decreases in the
amount of product generated at the end of the reaction,
and the double mutant demonstrates an additive e¡ect.
Interestingly, the Sug1 and Sug2 mutant extracts arrive
at the same endpoint by di¡erent routes (Fig. 5A,B).
The initial rate of product accumulation in the
SUG2T226C extracts is the same as in the WT extract.
However the rate of product accumulation decreases
quickly so that by the end of the 30 min incubation the
reaction rate is very slow. In contrast, the initial rate of
product accumulation in the SUG1T193C extract is lower
than that of the WT and SUG2T226C extracts. However,
the decrease in rate of product accumulation during the
incubation is not as dramatic as for the SUG2T226C ex-
Fig. 5. Kinetic assays suggest di¡erent functions for Sug1 and Sug2 in 26S proteasome peptidase activity. (A) Accumulation of product over a 30 min
time course in WT, single mutant, and double mutant strains either with or without NEM treatment. (B) Another representation of the data in A. In
each panel the product accumulation for extract of a single strain is shown either with or without pretreatment with NEM. In each case the top trace
is the untreated sample. See text for explanation.
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tract, so that roughly the same amount of product is pro-
duced by the endpoint.
The kinetics of product accumulation in the
SUG1T193CSUG2T226C strain can be described as the sum
of the two e¡ects, with both a change in the initial rate as
compared to the WT, and an accelerated decrease in rate
of product accumulation during the course of the assay.
Note that the relationship of the SUG1T193CSUG2T226C
trace to the SUG1T193C trace is similar to the relationship
of the SUG2T226C trace to the WT trace. The initial rate of
product accumulation is the same between the
SUG1T193CSUG2T226 extract and the SUG1T193C extract,
but then the two traces diverge due to an accelerated
decrease in rate of product generation by the
SUG1T193CSUG2T226 double mutant extract. Therefore,
the presence of the SUG2T226C mutation leads to a de-
creased ability to maintain peptidase activity over the
course of the reaction when present in either the WT or
SUG1T193C backgrounds. These results suggest that alky-
lation of Sug1 or Sug2 leads to inhibition of 26S peptidase
activity by di¡erent mechanisms.
3. Discussion
We have developed a strategy that allows individual
ATPases to be inhibited within the intact 26S proteasome.
Because the amino acid sequences of the proteasomal
ATPases are so similar to each other, particularly within
their ATP binding sites, our strategy does not rely on
¢nding an inhibitor speci¢c for each ATPase. Rather, we
have sensitized individual ATPases to an inhibitor with
limited speci¢city. Using this strategy, we have shown
that Sug1 and Sug2 have non-redundant functions within
the proteasome and can a¡ect to proteasomal peptidase
activity in di¡erent ways.
An analogy can be drawn between our chemical ap-
proach and the widely used genetic tact employing ts mu-
tants. In both cases a change in the environment a¡ects
the activity of a mutant protein more than the WT. The ts
strategy has been widely used, but it has several disadvan-
tages. First, ts mutants can be di⁄cult to ¢nd. It is not
usually possible to predict which residues, when mutated,
will make a protein sensitive to a change in temperature,
so a genetic screen or selection must be designed. Second,
it is often not clear what is happening to the mutant pro-
tein and any interacting partners upon temperature shift.
In the best case, the mutant protein loses activity without
being denatured or degraded. It is probably more often
the case that the protein is reversibly or irreversibly dena-
tured. In this case, interacting partners may also be lost to
proteolysis, making it unclear whether the mutant protein
is really responsible for the lost activity. In a subset of the
ts strains, the already synthesized mutant protein may be
una¡ected by the temperature shift, but newly synthesized
protein can not be correctly folded. In this case, the phe-
notype will take time to develop in vivo and the mutant
cannot be used for in vitro studies. Finally, ts mutants
often exhibit phenotypes even at the permissive temper-
ature. Thus, the biological process under study does not
behave normally even before the temperature shift, com-
plicating the interpretation.
In contrast, our strategy of making ‘chemical sensitive’
mutants has several advantages. Based on evidence in the
literature [21], we were able to predict an increase in sen-
sitivity to maleimides for AAA proteins having a cysteine
rather than a threonine at a highly conserved position
within the nucleotide binding motif. Because the mutation
was made in a region with a strongly predicted function
(nucleotide binding), we could anticipate with reasonable
con¢dence the consequences of alkylating the substituted
cysteine residue. Because the cysteine was placed in the
nucleotide binding pocket, it seemed likely that alkylation
by NEM would prevent ATP binding but not destabilize
the protein. Based on modeling of the Sug1T193C AAA
domain and virtual alkylation of the cysteines by NEM
(Fig. 2) it seems likely that the di¡erences seen in NEM
sensitivity between the WT and mutant extracts results
from blocking ATP binding to Sug1 and/or Sug2, and
not to a general disruption of the structure of the 19S
regulatory complex. Finally, there is no detectable defect
in proteasome function for any of the mutant strains in
the absence of NEM. Thus, indirect e¡ects due to defects
in proteolysis during the growth of the mutant strains are
unlikely. A disadvantage of this approach is that it is
probably limited to proteins that, like the AAA proteins,
have a residue that can be substituted with a cysteine in a
critical site. Its use is also limited to use with extracts or
puri¢ed proteins.
The use of NEM sensitizing mutations has allowed us to
assess the contribution of individual proteins to the func-
tion of a very large protein complex. The 20S, which has a
mass of approximately 700 kDa, can associate with either
one or two 19S complexes [30,31,10]. The 26S proteasome
contains at least 32 di¡erent polypeptides with a total
mass of approximately 700 Da. The mass for the double
capped complex is in excess of 2000 kDa [8]. In addition
there are six di¡erent, yet highly similar, AAA ATPases
which have nearly identical active sites ([14], and referen-
ces therein). Therefore, determining the contribution of
one ATPase to the function of the complex represented
a signi¢cant challenge. It is becoming increasingly clear
that many biological functions are performed by large
protein machines [32]. A challenge for the future is to
understand how each of their individual subunits contrib-
ute to the activity of the whole. Therefore, there will be a
growing need for novel strategies like the one presented
here.
The kinetic assays we report suggest that Sug1 and Sug2
have di¡erent roles in the function of the 26S proteasome.
Sug2 may function in maintaining the interaction between
the 19S and 20S proteasome. Because of the way the as-
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says were performed, we cannot address whether Sug2 is
also involved in the initial assembly of the 26S complex,
but this seems likely. It was expected that proteasomal
ATPases would be involved in assembly/stability of the
26S complex. The assembly process is known to be ATP
dependent and the interaction is stabilized in the presence
of ATP [14,10]. What is surprising is the apparently di¡er-
ent degree of involvement of Sug1 and Sug2 in maintain-
ing the 19S^20S interaction. The kinetic data suggest that
the main e¡ect of Sug1 alkylation is not to destabilize the
26S proteasome. A second requirement for ATPase activ-
ity may be opening of the axial pore. Immunoprecipitation
experiments designed to investigate the relative amounts of
19S associated with 20S following NEM treatment have
proved to be inconclusive, but we cannot rule out the
possibility that the ATPase activity is involved in protea-
somal assembly. It is also possible that allosteric activation
of the protease active sites is required. The fact that treat-
ments such as a low concentration of SDS can activate the
20S proteasome to the same degree as the 19S suggests
that a conformational change in the 20S is su⁄cient to
achieve activation. Therefore, Sug1 alkylation may either
restrict access of substrate to the proteolytic active sites or
result in failure to allosterically activate these sites. Con-
sistent with our ¢ndings, Rubin et al. have shown that a
variant of the AAA ATPase Rpt2 containing two muta-
tions (rpt2RF) does not a¡ect assembly of the 26S protea-
some [20]. However, the assembled 26S proteasome con-
taining rpt2RF has very little peptidase activity. This
suggests that the activity of Rpt2 is not required for the
ATP dependent assembly of the 26S proteasome, but has
another role in activating the 20S for peptide hydrolysis.
This mutant also points out an advantage of our approach
over making mutants with e¡ect on activity in the absence
of any intervention. The rpt2RF allele was isolated after a
conservative change in the Rpt2 Walker A box (K229R)
proved lethal. An intragenic suppressor was then isolated
(S241F), and it was the double mutant allele that was
studied. Thus it is not clear what relationship the pheno-
type has to the ATPase activity of the mutant protein.
ATPase activity may also be required for protein unfold-
ing, which would allow for e⁄cient processing through the
axial pore, but the manner in which our assays were per-
formed does not address that possibility.
The fact that our strategy works in the context of a
crude extract suggests that it can be used for another
type of experiment. While good inhibitors for the protease
activity of the 26S proteasome exist (lactacystin, epoxomi-
cin, peptide aldehydes), none are available to speci¢cally
inhibit the ATP dependent functions of the 19S regulatory
complex. Therefore, it has been di⁄cult to determine
whether the 19S complex might have functions separate
from assisting proteolysis by the 20S proteasome. Recently
we used the approach described in this work to test the
involvement of the proteasome in nucleotide excision re-
pair (NER). A role for the proteasome in NER was sug-
gested by the recently reported interaction with the NER
protein Rad23 [33]. WT and SUG1T193CSUG2T226C ex-
tracts competent for NER in vitro were treated in parallel
with NEM. NER activity was more sensitive to NEM in
extracts of the mutant than the WT strain. Surprisingly,
NER in vitro is not sensitive to the 20S proteasome in-
hibitor lactacystin. Therefore, we were able to use the
‘chemical sensitive’ mutation strategy to show that the
19S regulatory complex functions independently of pro-
teolysis in NER.
The inspiration for our strategy was the di¡erence in
NEM sensitivity between the human protein NSF and
its yeast ortholog Sec18. Our ¢ndings demonstrate that
the presence of a cysteine rather than a threonine at a
conserved position within the active site of two AAA pro-
teins can sensitize them to alkylation and inhibition by
NEM. Therefore, it seems likely that this is the reason
for observed di¡erences in NEM sensitivity between
NSF and Sec18. Although nearly all proteins are expected
to be NEM sensitive at some level, certain AAA proteins
are particularly sensitive. Our ¢ndings suggest a simple
explanation for this phenomenon. Clearly, this strategy
could be applied to the other four AAA proteins of the
proteasome to de¢ne their roles in 26S function, but we
propose that it may be more generally useful. Virtually
any AAA protein could be studied. If the critical Walker
A box position is occupied by a threonine, an NEM sen-
sitive mutant can be created by substituting a cysteine.
Alternatively, if this position is occupied by a cysteine a
NEM resistant mutant can be created by substitution of a
threonine. We hope that this approach will be useful for
the study of the proteins containing the AAA domain,
which have important roles in many cellular processes.
4. Signi¢cance
Functional studies regarding the properties of proteins
is commonly performed through inhibition of known ac-
tivities. Enzymatic inhibition has traditionally been
achieved via the use of ts mutant proteins, or by the
screening of chemical compounds for inhibitors to each
protein of interest. However, the nature of the inactivation
of ts mutant proteins is not well understood and these
proteins are usually limited in availability. Therefore, we
have developed a strategy for selectively inhibiting individ-
ual ATPases of the 19S regulatory particle of the protea-
some. This strategy involves using site directed mutagene-
sis of the ATPase active site in order to sensitize the
protein to the alkylating agent NEM. Using this tech-
nique, we ¢nd that the mutation of the protein does not
a¡ect the activity of the proteasome in the absence of
NEM. In addition, our NEM-based strategy has allowed
for the study of the contribution of individual subunits to
the function of a large multiprotein complex. Kinetic as-
says performed suggest that the two proteins tested in this
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study, Sug1 and Sug2, do not possess redundant functions
in protein degradation. The AAA protein family consists
of a large number of proteins that function in various
processes within the cell. Considering the similarity in ami-
no acid sequence of the proteins in the AAA family, this
approach may be useful in the study of the involvement of
the role of AAA proteins in cellular processes.
5. Materials and methods
5.1. Sequence comparisons and modeling
Sequences of AAA proteins for comparison were obtained
from the AAA proteins database maintained by K.U. Froelich
(available at http://yeamob.pci.chemie.uni-tuebingen.de/AAA).
The closest AAA protein for which a crystal structure is available
is of the D2 domain of NSF complexed with Mg2-AMPPNP
[25,34]. The region around the ATP binding site is highly con-
served and therefore could be used for modeling the Sug1 ATP
binding site. Modeling was done by threading the Sug1 sequence
with the T193C mutation into the NSF structure (PDB code:
1D2N). The most common rotamers were used initially. The
model was examined and manually adjusted using O [35]. The
only signi¢cant adjustment that was necessary was a rotation of
lysine 195 for Sug1. In NSF, the amino group, Nj of this lysine
interacts with one of the Q-phosphate oxygens of ATP. This was
rotated such that it interacts with a di¡erent oxygen on the same
phosphate group. NEM was incorporated into the model by
superimposing a cysteine-bound NEM derivative [N-2-(1-male-
imidyl)ethyl]-7-(diethylamino)coumarin-3-carboxamide (MDCC),
from the crystal structure of phosphate binding protein (PBP)
labeled with MDCC [36]. The coumaryl derivative bound to the
nitrogen of maleimide was trimmed down to an ethyl group.
Reaction of a cysteine with MDCC creates a new chiral center
resulting in two diastereoisomers of the MDCC^PBP complex.
Both are observed in the crystal structure. When superimposing
the two cysteinyl-NEM moieties extracted from this, only one can
be modeled into the ATP-binding region of Sug1 without clash-
ing into the protein main chain.
5.2. Yeast strains
Site directed mutagenesis of Sug1 and Sug2 was performed
with the Amersham Sculptor kit according to the manufacturer’s
instructions. The parental plasmids were pJS#159 and pSJR#87
which are pUC118 derivatives carrying the SUG1 and SUG2
genes respectively, including 5P and 3P untranslated regions. Oligo
SJR#64 (5P-GGTTTTCCCGCAGCCAGGGGGG-3P) was used
to make a mutation encoding T193C and insert a Bgl1 site. Oligo
SJR#65 (5P-GTTTTACCACACCCGGGGGGACC-3P) was used
to make a mutation encoding T226C and insert a Sma1 site. The
plasmid produced was pSJR175 (SUG1T193C). It was digested
with EcoR1/Kpn1 to isolate an integration fragment. pSJR176
(SUG2T226C) was digested with BstE2/Cla1 for integration.
Strains containing these mutant alleles were constructed using a
two step gene replacement strategy. Strains Sc500 (SUG1: :URA3
pMTL-SUG1) and Sc530 (SUG2: :URA3 pMTL-SUG2) were
transformed with the SUG1T193C and SUG2T226C fragments re-
spectively. Strains Sc500 and Sc530 depend on expression of
SUG1 and SUG2, respectively, from the pMTL plasmids under
control of the GAL promoter. Therefore, they survive only on
galactose, which induces this promoter. After transformation, the
strains were plated on glucose, which selects for transformants in
which homologous integration occurs and SUG1 or SUG2 is now
expressed from its own promoter. These strains were screened for
correct integration by PCR and digestion of the ampli¢cation
product at the restriction sites inserted for the purpose. The
two single mutant strains produce were crossed and sporulated.
The SUG1 and SUG2 genes were PCR ampli¢ed from individual
spores. The PCR products were digested with Bgl1 (SUG1) and
Sma1 (SUG2) to screen for single and double mutant segregants.
The PCR products from candidate strains were sequenced com-
pletely to verify that only the desired mutations were present. In
this way a set of four congenic strains were produced which had
the SUG1T193 allele and WT SUG2, the SUG2T226 allele and WT
SUG1, both mutant alleles, or two WT alleles.
5.3. Alkylation with biotin maleimide
Biotin maleimide (2-(N-maleimidopropionyl)-biocytin) was dis-
solved at a concentration of 10 mM in dimethylformamide
(DMF). This solution was diluted with water to a ¢nal concen-
tration of 5 mM, 50% DMF. Whole cell extracts in extract bu¡er
(50 mM Tris, pH 7.5, 5 mM MgCl2, 5 mM ATP, 10% glycerol)
were treated with a ¢nal concentration of 0.5 mM biotin male-
imide (5% DMF) for 2 h before quenching the reaction with
5 mM DTT. Unreacted biotin maleimide was then removed by
spun column gel ¢ltration of the treated extracts through Centri-
sep columns (Princeton separations) equilibrated with extract
bu¡er. The 26S proteasome complex was then dissociated by
adding guanidinium hydrochloride to 8 M and incubating at
37‡C for 10 min. The guanidinium chloride concentration was
reduced to 4 M by the addition of an equal volume of extract
bu¡er and biotinylated proteins were isolated by binding to
streptavidin agarose (Boehringer Mannheim). The beads were
extensively washed with 4 M guanidinium hydrochloride in ex-
tract bu¡er, then rinsed with 4 M urea. Bound proteins were
released by autoclaving the beads in 2USDS loading bu¡er, sep-
arated by SDS^PAGE, and detected by Western blot.
5.4. Measurements of proteasomal peptidase activity
NEM was dissolved at a concentration of 2 M in ethanol, then
serially diluted in water to 40 mM NEM, 2% ethanol. Serial
dilutions were then made in 2% ethanol. Extracts were treated
with NEM for 15 min on ice before quenching unreacted NEM
by addition of DTT to 5 mM. Peptidase activity assays were
performed by diluting 10 Wl of treated extract into 100 Wl of
Succ-LLVY-AMC substrate mix [16] Reactions were incubated
at 30‡C for 30 min. For assay of 20S activity, NaCl was added
to 150 mM and the extracts were incubated overnight at 4‡C to
allow the 19S regulatory complex to dissociate from the 20S
proteasome. Peptidase activity was then assayed as above except
that the substrate mix contained 0.05% SDS. Kinetic peptidase
assays were performed in a Tecan £uorescence plate reader. The
reactions were started simultaneously by the addition of pre-
warmed substrate mix to wells containing treated extract with a
multichannel pipetter. The plate was then incubated at 30‡C with
shaking between each measurement. The £uorescence in each well
was measure every 30 s for 30 min.
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